Different clinical significance of FGFR1–4 expression between diffuse-type and intestinal-type gastric cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Different clinical significance of FGFR1–4 expression between diffuse-type and intestinal-type gastric cancer
Authors
Keywords
Fibroblast growth factor receptor 1, Fibroblast growth factor receptor 2, Fibroblast growth factor receptor 3, Fibroblast growth factor receptor 4, Gastric cancer, Immunohistochemistry
Journal
World Journal of Surgical Oncology
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-01-05
DOI
10.1186/s12957-016-1081-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer
- (2015) Chee Leong Cheng et al. BREAST CANCER RESEARCH AND TREATMENT
- Fibroblast growth factor receptor 1 gene amplification in gastric adenocarcinoma
- (2015) Manuel H. Schäfer et al. HUMAN PATHOLOGY
- Fibroblast Growth Factor Receptor 1 Gene Copy Number and mRNA Expression in Primary Colorectal Cancer and Its Clinicopathologic Correlation
- (2015) Yoonjin Kwak et al. PATHOBIOLOGY
- Clinicopathological Variation of Lauren Classification in Gastric Cancer
- (2015) Yun-Chi Chen et al. PATHOLOGY & ONCOLOGY RESEARCH
- Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer
- (2015) Hao Chen WORLD JOURNAL OF GASTROENTEROLOGY
- The prognostic significance of fibroblast growth factor receptor 4 in non-small-cell lung cancer
- (2015) Hong-ping Huang et al. OncoTargets and Therapy
- Therapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer
- (2015) Mikito Inokuchi et al. Gastroenterology Research and Practice
- Clinical significance of MET in gastric cancer
- (2015) Mikito Inokuchi World Journal of Gastrointestinal Oncology
- Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma
- (2015) Hyo Song Kim et al. Oncotarget
- Fibroblast growth factor receptor 4 as a potential prognostic and therapeutic marker in colorectal cancer
- (2014) Chen-Sheng Li et al. BIOMARKERS
- FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study
- (2014) X Su et al. BRITISH JOURNAL OF CANCER
- Mutually exclusive FGFR2, HER2, and KRAS gene amplifications in gastric cancer revealed by multicolour FISH
- (2014) Kakoli Das et al. CANCER LETTERS
- Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma
- (2014) Akiko Kawano Nagatsuma et al. Gastric Cancer
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
- (2014) Kai Wang et al. NATURE GENETICS
- Prognostic Value of FGFR Gene Amplification in Patients with Different Types of Cancer: A Systematic Review and Meta-Analysis
- (2014) Jinjia Chang et al. PLoS One
- Photoactivation Approaches Reveal a Role for Rab11 in FGFR4 Recycling and Signalling
- (2014) Ellen M. Haugsten et al. TRAFFIC
- Pathohistological classification systems in gastric cancer: Diagnostic relevance and prognostic value
- (2014) Felix Berlth WORLD JOURNAL OF GASTROENTEROLOGY
- FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
- (2014) Elizabeth A. Guancial et al. Cancer Medicine
- FGFR4 Promotes Stroma-Induced Epithelial-to-Mesenchymal Transition in Colorectal Cancer
- (2013) R. Liu et al. CANCER RESEARCH
- Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China
- (2013) Miao-zhen Qiu et al. Journal of Translational Medicine
- MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas
- (2013) Sang Y Ha et al. MODERN PATHOLOGY
- Nuclear EGFR as a molecular target in cancer
- (2013) Toni M. Brand et al. RADIOTHERAPY AND ONCOLOGY
- FGFR2, HER2 and cMet in gastric adenocarcinoma: detection, prognostic significance and assessment of downstream pathway activation
- (2013) Guy Betts et al. VIRCHOWS ARCHIV
- FGFR2 gene amplification and clinicopathological features in gastric cancer
- (2012) K Matsumoto et al. BRITISH JOURNAL OF CANCER
- Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer
- (2012) A. N. Brooks et al. CLINICAL CANCER RESEARCH
- A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
- (2012) Niantao Deng et al. GUT
- Fibroblast growth factor receptor 2 gene amplification status and its clinicopathologic significance in gastric carcinoma
- (2012) Eun-Jung Jung et al. HUMAN PATHOLOGY
- The correlations between the expression of FGFR4 protein and clinicopathological parameters as well as prognosis of gastric cancer patients
- (2012) Yan-Wei Ye et al. JOURNAL OF SURGICAL ONCOLOGY
- Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression
- (2011) Yan Wei Ye et al. CANCER
- Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes-A systematic review
- (2011) Terence C. Chua et al. INTERNATIONAL JOURNAL OF CANCER
- A Novel, Selective Inhibitor of Fibroblast Growth Factor Receptors That Shows a Potent Broad Spectrum of Antitumor Activity in Several Tumor Xenograft Models
- (2011) G. Zhao et al. MOLECULAR CANCER THERAPEUTICS
- The Fibroblast Growth Factor Receptor-4 Arg388 Allele is Associated with Gastric Cancer Progression
- (2010) Yanwei Ye et al. ANNALS OF SURGICAL ONCOLOGY
- Monoclonal Antibodies to Fibroblast Growth Factor Receptor 2 Effectively Inhibit Growth of Gastric Tumor Xenografts
- (2010) W.-m. Zhao et al. CLINICAL CANCER RESEARCH
- Immunohistochemical Detection of Fibroblast Growth Factor Receptor 3 in Human Breast Cancer: Correlation with Clinicopathological/Molecular Parameters and Prognosis
- (2010) Kazuko Kuroso et al. PATHOBIOLOGY
- Comparative Study on Overexpression of HER2/neu and HER3 in Gastric Cancer
- (2009) Xiu Li Zhang et al. WORLD JOURNAL OF SURGERY
- Assessment of a HER2 scoring system for gastric cancer: results from a validation study
- (2008) M Hofmann et al. HISTOPATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started